drugset

drugset / Trial / NCT04676737

TTHX1114(NM141) in Combination With DWEK/DSO

NCT04676737 ↗

Phase 2 Completed 49 enrolled Trefoil Therapeutics, Inc.

Non-randomizedParallel-groupOpen-labelTreatment

Summary

Open label, single-treatment, with a concurrent non-treatment control

Timeline

Start: 2021-02-01
Primary completion: 2022-11-16
Completion: 2023-01-13

Publications

Moloney G, Al-Zanki S, Burgos-Blasco B, Fadaifard Martinez M, Bujak M, Dhaliwal DK. Severe Corneal Flattening After Endothelial Keratoplasty: Collagen Compaction Syndrome. Cornea. 2024 Nov 7;44(5):653-658. doi: 10.1097/ICO.0000000000003752.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	TTHX1114	Protein / enzyme biologic	—	—

Indications